Amneal Pharmaceuticals (AMRX) Goodwill (2017 - 2026)

Amneal Pharmaceuticals' Goodwill history runs 10 years deep, the most recent figure standing at $593.8 million for Q1 2026.

• On a quarterly basis, Goodwill fell 0.62% year-over-year to $593.8 million in Q1 2026; TTM through Mar 2026 was $593.8 million, a 0.62% decrease from a year earlier, with the FY2025 full-year figure at $595.5 million, changed 0.33% from the prior year.
• Goodwill steadied at $593.8 million in Q1 2026 per AMRX's latest filing, from $595.5 million in the prior quarter.
• Across five years, Goodwill topped out at $602.9 million in Q1 2022 and bottomed at $593.8 million in Q1 2026.
• The 5-year median for Goodwill is $598.5 million (2024), against an average of $598.3 million.
• Across the five-year window, Goodwill advanced 15.33% in 2022 and fell 0.62% in 2023, its largest moves.
• Year by year, Goodwill stood at $598.9 million in 2022, then fell by 0.04% to $598.6 million in 2023, then decreased by 0.2% to $597.4 million in 2024, then dropped by 0.33% to $595.5 million in 2025, then fell by 0.28% to $593.8 million in 2026.
• Per Business Quant, the three latest AMRX Goodwill figures stand at $593.8 million (Q1 2026), $595.5 million (Q4 2025), and $595.9 million (Q3 2025).